Company Financials

Harrow Health, Inc. Financials

United States dollar

business Harrow Health, Inc. Company Profile

Main Stock Listing

NASDAQ: HROW

Market Capitalization $1.85 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -101.86
Forward PE 22.82
Price to Sales TTM $7.39
Price to Book MRQ $39.30
Enterprise to Revenue 8.09
Enterprise to EBITDA 43.83

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -1.99%
Operating Margin 20.58%
Return on Assets TTM 4.91%
Return on Equity TTM -9.57%

Income Statement

Revenue TTM $250,042,000
Revenue per Share TTM $6.87
Quarterly Revenue Growth 45.40%
Gross Profit TTM $186,440,992
EBITDA $23,427,000
Net Income to Common TTM $-4,988,000
Diluted EPS TTM $-0.13
Quarterly Earnings Growth YoY 45.44%

Balance Sheet

Total Cash MRQ $77,456,000
Total Cash per Share MRQ $2.09
Total Debt MRQ $
Total Debt to Equity MRQ 539.79
Current Ratio MRQ 2.72
Book Value per Share MRQ $1.27

Cash Flow

Operating Cash Flow TTM $17,674,000
Levered Free Cash Flow TTM $-55,710,124

HROW Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 37,034,582
Float Shares 27,131,045
Avg 10 Volume 480,960
Avg 30 Volume None
Shares Short 5,599,873
Short Ratio 10.54
Short % of Shares 19.06%
% Held by Insiders 15.70%
% Held by Institutions 58.38%

Stock Price Summary

Beta 0.07
Fifty Two Week Low $20.85
Fifty Two Week High $51.53
Fifty Two Week Change 27.95%
Day 50 MA $42.30
Day 200 MA $35.32

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2013-02-08